文献速递腹部介入CTMR

立体定向体部放疗作为肝移植桥接治疗肝细胞癌的影像学肿瘤反应与组织病理学对照

Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation.
PubMed 文献 · Abdom Radiol (NY) · 2020-10-19

回顾性分析23例患者25个肝细胞癌病灶,在接受立体定向体部放疗作为肝移植桥接治疗后,于移植前影像评估肿瘤直径与坏死百分比并与 explant 病理对照。移植前影像与病理的肿瘤大小及坏死百分比呈正相关;按 RECIST 1.1 评估的影像学反应可能低估 SBRT 疗效,而影像学坏死百分比与病理坏死百分比相关性更密切。

要点

  • 移植前影像与 explant 病理的肿瘤大小及坏死百分比呈正相关。
  • RECIST 1.1 影像学反应可能低估 SBRT 治疗后的肿瘤坏死程度。
  • 影像学评估的肿瘤坏死百分比与病理坏死百分比相关性更密切。

核心结论

  • RECIST 1.1 影像学反应标准可能低估 SBRT 的治疗反应,影像学评估的肿瘤坏死百分比与病理坏死百分比相关性更密切。

研究设计与样本

  • 回顾性研究,经机构审查委员会批准,纳入12年间在单一三级转诊机构接受 SBRT 作为肝移植桥接治疗后行肝移植的23例患者共25个肝细胞癌病灶(20例男性;中位年龄60岁,范围41-68岁)。
  • 目标病灶在移植前增强 CT 或 MRI 上评估影像生物标志物,包括肝细胞癌直径变化和坏死百分比评估,并与 explant 病理对照。

关键影像表现/征象

  • 移植前影像与病理的肿瘤大小呈正相关(Spearman ρ=0.86;p<0.001),坏死百分比亦呈正相关(p<0.001)。
  • 移植前影像按 RECIST 1.1 评估:部分缓解8个(32%)、疾病稳定15个(60%)、疾病进展2个(8%)。
  • 15个影像学疾病稳定病灶中,5/15(33%)在 SBRT 后影像上显示坏死超过50%,而9/15(60%)在 explant 病理分析中显示坏死超过50%,提示影像倾向于低估肿瘤坏死程度。

诊断标准与关键数值

  • RECIST 1.1 用于移植前影像学反应评估,分为部分缓解、疾病稳定和疾病进展。
  • 影像学肿瘤坏死百分比与病理坏死百分比相关(p<0.001)。

临床应用与阅片要点

  • 阅片时可同时评估肿瘤直径变化和坏死百分比,而非仅依赖 RECIST 1.1 反应分类。
  • 对 RECIST 1.1 判为疾病稳定的 SBRT 后病灶,应注意影像可能低估坏死程度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the imaging findings of hepatocellular carcinoma (HCC) treated with stereotactic body radiation therapy (SBRT) as a bridging therapy prior to liver transplantation (LT), with histopathological correlation at liver explant.

METHODS: Our institutional review board approved this retrospective study. The study subjects included 25 HCC lesions in 23 patients (20 males; median age, 60 years; range 41-68 years) who underwent LT after SBRT for HCC as a bridge to LT in a single tertiary referral institution over a 12-year period. Target HCC lesions were assessed for imaging biomarkers on contrast-enhanced CT or MRI including change in HCC diameter and assessment of percentage necrosis. The radiologic response at pre-LT imaging was compared to explant pathology.

RESULTS: There was a positive correlation between the tumor size (Spearman's ρ = 0.86; p < 0.001) and percentage necrosis (p < 0.001) on Pre-LT imaging and those on pathology. Partial response (PR), stable disease (SD), and progressive disease (PD) according to RECIST 1.1 were seen in 8 (32%), 15 (60%), and 2 (8%) lesions on pre-LT imaging, respectively. Of the 15 lesions with radiologic SD, 5/15 (33%) showed necrosis of more than 50% on post-SBRT imaging, while 9/15 (60%) showed necrosis of more than 50% at explant pathologic analysis, showing a tendency to underestimate the degree of tumor necrosis compared to pathology.

CONCLUSION: RECIST 1.1 radiologic response criteria may underestimate the response to treatment with SBRT, and radiologic estimation of percent tumor necrosis was more closely correlated with pathologic percent tumor necrosis.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Mastrocostas K, Fischer S, Munoz-Schuffenegger P, et al. Radiological tumor response and histopathological correlation of hepatocellular carcinoma treated with stereotactic body radiation therapy as a bridge to liver transplantation. Abdom Radiol (NY). 2020. PMID: 33074426. doi:10.1007/s00261-020-02821-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。